Carregant...
Adoption of Sacubitril/Valsartan for the Management of Patients with Heart Failure
BACKGROUND: The United States Food and Drug Administration (FDA) approved the use of sacubitril/valsartan in patients with heart failure (HF) and reduced ejection fraction (HFrEF) in July 2015We aimed to assess the adoption and prescription drug costs of sacubitril/valsartan in its first 18 months f...
Guardat en:
| Publicat a: | Circ Heart Fail |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5820776/ https://ncbi.nlm.nih.gov/pubmed/29453287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004302 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|